ANI Pharmaceuticals Inc (ANIP) — Cash Flow-to-Debt Ratio
ANI Pharmaceuticals Inc (ANIP) has a Cash Flow-to-Debt Ratio of 0.03x as of December 2025, meaning its operating cash flow of $30.37 Million could theoretically repay 0% of its total liabilities ($899.65 Million) in one year. See ANI Pharmaceuticals Inc (ANIP) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ANI Pharmaceuticals Inc Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for ANI Pharmaceuticals Inc across 28 annual periods. For the full cash flow conversion analysis, see ANIP cash flow conversion.
Annual Cash Flow-to-Debt Ratio for ANI Pharmaceuticals Inc (1998–2025)
Year-by-year debt coverage analysis for ANI Pharmaceuticals Inc. Check ANI Pharmaceuticals Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.21x | $185.22 Million | $899.65 Million | ▲ +175.0% |
| 2024 | 0.07x | $64.02 Million | $855.17 Million | ▼ -71.9% |
| 2023 | 0.27x | $118.96 Million | $446.82 Million | ▲ +459.7% |
| 2022 | -0.07x | $-31.20 Million | $421.55 Million | ▼ -1019.9% |
| 2021 | 0.01x | $3.32 Million | $412.86 Million | ▼ -86.0% |
| 2020 | 0.06x | $15.27 Million | $265.49 Million | ▼ -69.3% |
| 2019 | 0.19x | $45.63 Million | $244.00 Million | ▼ -34.9% |
| 2018 | 0.29x | $67.07 Million | $233.34 Million | ▲ +73.1% |
| 2017 | 0.17x | $39.42 Million | $237.38 Million | ▼ -7.4% |
| 2016 | 0.18x | $27.47 Million | $153.22 Million | ▲ +30.0% |
| 2015 | 0.14x | $17.26 Million | $125.18 Million | ▼ -22.4% |
| 2014 | 0.18x | $22.03 Million | $123.92 Million | ▲ +111.5% |
| 2013 | -1.55x | $-5.48 Million | $3.54 Million | ▲ +35.1% |
| 2012 | -2.39x | $-25.28 Million | $10.59 Million | ▼ -22.5% |
| 2011 | -1.95x | $-47.87 Million | $24.56 Million | ▼ -24.5% |
| 2010 | -1.57x | $-40.10 Million | $25.62 Million | ▼ -75.0% |
| 2009 | -0.89x | $-18.43 Million | $20.61 Million | ▲ +77.8% |
| 2008 | -4.03x | $-15.54 Million | $3.85 Million | ▼ -926.0% |
| 2007 | 0.49x | $739.99K | $1.52 Million | ▲ +142.0% |
| 2006 | -1.16x | $-5.00 Million | $4.30 Million | ▲ +61.4% |
| 2005 | -3.01x | $-8.30 Million | $2.76 Million | ▲ +45.0% |
| 2004 | -5.48x | $-10.44 Million | $1.91 Million | ▲ +12.6% |
| 2003 | -6.27x | $-5.52 Million | $881.21K | ▼ -98.7% |
| 2002 | -3.15x | $-3.96 Million | $1.26 Million | ▼ -60.5% |
| 2001 | -1.97x | $-1.82 Million | $927.76K | ▲ +42.3% |
| 2000 | -3.41x | $-3.21 Million | $941.26K | ▲ +37.3% |
| 1999 | -5.43x | $-1.79 Million | $329.12K | ▼ -46.1% |
| 1998 | -3.72x | $-3.04 Million | $817.91K | — |